Skip to main content
Evotec SE (EVOTF)
OTCMKTS · Delayed Price · Currency is USD
8.27
-0.95 (-10.29%)
At close: Jan 21, 2025

Evotec SE Revenue

In the year 2024, Evotec SE had annual revenue of 796.97M EUR with 1.99% growth. Evotec SE had revenue of 221.23M in the quarter ending December 31, 2024, with 9.89% growth.

Revenue
796.97M EUR
Revenue Growth
+1.99%
P/S Ratio
1.77
Revenue / Employee
168.14K EUR
Employees
4,740
Market Cap
1.46B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024796.97M15.54M1.99%
Dec 31, 2023781.43M29.98M3.99%
Dec 31, 2022751.45M133.41M21.59%
Dec 31, 2021618.03M117.11M23.38%
Dec 31, 2020500.92M54.49M12.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
Glass House Brands 200.90M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Evotec SE News

More News